June 2026 saw drug development in oncology and neurology continue and biotech deals over small molecules and RNA therapies ...
Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...
Parabilis Medicines, NewLimit, Enliven Therapeutics, and Kardigan bagged the biggest biotech funding rounds overall in June 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results